Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myriam Labopin

Showing results (121-130 of 443) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|June 30, 2022
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Arnon Nagler, Myriam Labopin, Jan J Cornelissen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2018
Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN StudyYazid Belkacemi, Myriam Labopin, Sebastian Giebel, et al.
Journal of Hematology & Oncology|March 19, 2023
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYishan Ye, Myriam Labopin, Jia Chen, et al.
Journal of Hematology & Oncology|October 8, 2015
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow TransplantationFrédéric Baron, Myriam Labopin, Annalisa Ruggeri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2020
Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAnnalisa Ruggeri, Myriam Labopin, Giorgia Battipaglia, et al.
Haematologica|August 16, 2019
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin <i>versus</i> allogeneic bone marrow transplantation without anti-thymocyte globulinFrédéric Baron, Jacques-Emmanue Galimard, Myriam Labopin, et al.
European Journal of Haematology|March 27, 2015
Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationSandra Eder, Myriam Labopin, William Arcese, et al.
Leukemia|March 9, 2019
Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemiaJonathan Canaani, Myriam Labopin, Maija Itälä-Remes, et al.
Bone Marrow Transplantation|September 19, 2019
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT studyKatie S Gatwood, Myriam Labopin, Bipin N Savani, et al.
Pageof 45

Showing results (121-130 of 443) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|June 30, 2022
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Arnon Nagler, Myriam Labopin, Jan J Cornelissen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 5, 2019
Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAvichai Shimoni, Myriam Labopin, Bipin Savani, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2018
Single-Dose Daily Fractionation Is Not Inferior to Twice-a-Day Fractionated Total-Body Irradiation Before Allogeneic Stem Cell Transplantation for Acute Leukemia: A Useful Practice Simplification Resulting From the SARASIN StudyYazid Belkacemi, Myriam Labopin, Sebastian Giebel, et al.
Journal of Hematology & Oncology|March 19, 2023
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationYishan Ye, Myriam Labopin, Jia Chen, et al.
Journal of Hematology & Oncology|October 8, 2015
Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow TransplantationFrédéric Baron, Myriam Labopin, Annalisa Ruggeri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2020
Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAnnalisa Ruggeri, Myriam Labopin, Giorgia Battipaglia, et al.
Haematologica|August 16, 2019
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin <i>versus</i> allogeneic bone marrow transplantation without anti-thymocyte globulinFrédéric Baron, Jacques-Emmanue Galimard, Myriam Labopin, et al.
European Journal of Haematology|March 27, 2015
Thiotepa-based versus total body irradiation-based myeloablative conditioning prior to allogeneic stem cell transplantation for acute myeloid leukaemia in first complete remission: a retrospective analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationSandra Eder, Myriam Labopin, William Arcese, et al.
Leukemia|March 9, 2019
Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemiaJonathan Canaani, Myriam Labopin, Maija Itälä-Remes, et al.
Bone Marrow Transplantation|September 19, 2019
Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT studyKatie S Gatwood, Myriam Labopin, Bipin N Savani, et al.
Pageof 45